You are here: Home » News-CM » Companies » Results
Business Standard

Bafna Pharmaceuticals reports standalone net loss of Rs 7.61 crore in the June 2017 quarter

Capital Market 

Sales decline 56.99% to Rs 9.10 crore

Net Loss of reported to Rs 7.61 crore in the quarter ended June 2017 as against net loss of Rs 2.90 crore during the previous quarter ended June 2016. Sales declined 56.99% to Rs 9.10 crore in the quarter ended June 2017 as against Rs 21.16 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales9.1021.16 -57 OPM %-33.853.64 -PBDT-4.98-1.94 -157 PBT-5.91-2.95 -100 NP-7.61-2.90 -162

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU